Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atonal bHLH transcription factor 8 (ATOH8) is a member of the basic helix-loop-helix (bHLH) protein superfamily and functions primarily as a transcription factor, regulating gene expression by binding to E-box DNA sequences, often as a heterodimer with other bHLH proteins[1][3]. ATOH8 is evolutionarily conserved in its DNA-binding domain, while other regions are variable, and shows temporally and spatially restricted expression during embryogenesis and organogenesis in multiple tissues, including brain, kidney, skeletal muscle, pancreas, cartilage, and bone[1][2][3]. ATOH8's main biological role is in determining cell fate, promoting or repressing differentiation and proliferation in a highly tissue-dependent manner. For example, it acts as a positive regulator of chondrocyte proliferation in bone development, is necessary for proper neuronal and pancreatic differentiation, plays a role in endothelial cell regulation, and is implicated in transition phases of myogenesis[2][3][1]. In cancer, ATOH8 generally functions as a tumor suppressor, but can also act as a proliferation activator in specific cancer types such as colorectal cancer[1][2]. Functionally, ATOH8 impacts SMAD signaling and interacts with developmental signals such as BMP and TGF-β pathways[3]. In adults, it is implicated in iron metabolism, cellular stress responses, and homeostasis, possibly via modulation of genes involved in these processes[1]. No direct small-molecule drugs are known to target ATOH8, and there are currently no therapies specifically modulating its activity. However, its expression patterns and downstream targets nominate it as a biomarker candidate for certain cancers and metabolic diseases. Therapeutic modulation of ATOH8 would require caution due to its broad developmental roles and potential for multi-organ effects[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atonal bHLH transcription factor 8 (ATOH8).